94 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
of ADSs are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary bank, the custodian … will only issue ADSs in whole numbers.
When a holder makes a deposit of ordinary shares, such holder will be responsible for transferring good and valid
8-K
EX-5.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
; and
it should be understood that we have not been responsible for investigating or verifying (i) the accuracy of the facts, including statements
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary bank, the custodian, us or any … numbers.
When a holder makes a deposit of ordinary shares, such holder will be responsible for transferring good and valid title to the depositary
S-3ASR
jhs05u2 95l10
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-4.6
zr45v
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
efzt7 n3x
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-5.1
mbdrkq
11 Sep 24
Automatic shelf registration
4:01pm
DEFA14A
5hm7j frra
20 May 24
Additional proxy soliciting materials
8:48pm
PRE 14A
4fp16xpo
26 Apr 24
Preliminary proxy
4:36pm
424B5
ytc757a2uh9676qdvwic
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-5.1
nr770yyjx e015yn5c4s
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am